Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Kidney Int. 2011 Mar 9;79(12):1370–1378. doi: 10.1038/ki.2011.47

Figure 1. Prevalence of hyperphosphatemia, secondary hyperparathyroidism and elevated FGF23 in relation to eGFR.

Figure 1

Hyperphosphatemia was defined as serum phosphate ≥ 4.6 mg/dl, secondary hyperparathyroidism as PTH ≥ 65 pg/ml and FGF23 excess as FGF23 ≥ 100 RU/ml.